103 related articles for article (PubMed ID: 16416268)
1. Evaluation of a novel kit for the rapid detection of extended-spectrum beta-lactamases.
Colodner R; Reznik B; Gal V; Yamazaki H; Hanaki H; Kubo R
Eur J Clin Microbiol Infect Dis; 2006 Jan; 25(1):49-51. PubMed ID: 16416268
[TBL] [Abstract][Full Text] [Related]
2. [Evaluation of the MicroScan NegCombo panel Type 44 for detection of extended-spectrum beta-lactamase among clinical isolates of Escherichia coli, Klebsiella species, and Proteus mirabilis].
Ko SY; Chung JW; Song AJ; Yoon NS; Sung H; Kim MN
Korean J Lab Med; 2009 Feb; 29(1):35-40. PubMed ID: 19262076
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the Clinical and Laboratory Standards Institute phenotypic confirmatory test to detect the presence of extended-spectrum β-lactamases from 4005 Escherichia coli, Klebsiella oxytoca, Klebsiella pneumoniae and Proteus mirabilis isolates.
Morrissey I; Bouchillon SK; Hackel M; Biedenbach DJ; Hawser S; Hoban D; Badal RE
J Med Microbiol; 2014 Apr; 63(Pt 4):556-561. PubMed ID: 24478449
[TBL] [Abstract][Full Text] [Related]
4. [Evaluation of the Phoenix automated microbiology system for detecting extended-spectrum beta-lactamase in Escherichia coli, Klebsiella species and Proteus mirabilis].
Lee KK; Kim ST; Hong KS; Huh HJ; Chae SL
Korean J Lab Med; 2008 Jun; 28(3):185-90. PubMed ID: 18594169
[TBL] [Abstract][Full Text] [Related]
5. Predicament in Detection and Reporting of Extended Spectrum Beta Lactamase Production in Routine Antibiotic Susceptibility Testing.
Butt T; Raza S; Butt E
J Coll Physicians Surg Pak; 2017 Dec; 27(12):788-790. PubMed ID: 29185411
[TBL] [Abstract][Full Text] [Related]
6. Detection of AmpC beta-lactamases in Escherichia coli, Klebsiella spp., Salmonella spp. and Proteus mirabilis in a regional clinical microbiology laboratory.
Pitout JD; Le PG; Moore KL; Church DL; Gregson DB
Clin Microbiol Infect; 2010 Feb; 16(2):165-70. PubMed ID: 19456838
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the current National Committee for Clinical Laboratory Standards guidelines for screening and confirming extended-spectrum beta-lactamase production in isolates of Escherichia coli and Klebsiella species from bacteremic patients.
Katz OT; Peled N; Yagupsky P
Eur J Clin Microbiol Infect Dis; 2004 Nov; 23(11):813-7. PubMed ID: 15480883
[TBL] [Abstract][Full Text] [Related]
8. In vitro activity of flomoxef and comparators against Escherichia coli, Klebsiella pneumoniae and Proteus mirabilis producing extended-spectrum β-lactamases in China.
Yang Q; Zhang H; Cheng J; Xu Z; Xu Y; Cao B; Kong H; Ni Y; Yu Y; Sun Z; Hu B; Huang W; Wang Y; Wu A; Feng X; Liao K; Shen D; Hu Z; Chu Y; Lu J; Su J; Gui B; Duan Q; Zhang S; Shao H
Int J Antimicrob Agents; 2015 May; 45(5):485-90. PubMed ID: 25600890
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of a double synergy differential test (DSDT) for differential detection of ESBL and AmpC-type β-lactamases in Escherichia coli, Klebsiella pneumoniae and Proteus mirabilis.
Sabia C; Gargiulo R; Sarti M
New Microbiol; 2012 Apr; 35(2):221-5. PubMed ID: 22707136
[TBL] [Abstract][Full Text] [Related]
10. Use of boronic acid disk methods to detect the combined expression of plasmid-mediated AmpC beta-lactamases and extended-spectrum beta-lactamases in clinical isolates of Klebsiella spp., Salmonella spp., and Proteus mirabilis.
Song W; Jeong SH; Kim JS; Kim HS; Shin DH; Roh KH; Lee KM
Diagn Microbiol Infect Dis; 2007 Mar; 57(3):315-8. PubMed ID: 17174510
[TBL] [Abstract][Full Text] [Related]
11. [Phenotypic and molecular identification of extended-spectrum beta-lactamase (ESBL) TEM and SHV produced by clinical isolates Escherichia coli and Klebsiella spp. in hospitals].
González Mesa L; Ramos Morí A; Nadal Becerra L; Morffi Figueroa J; Hernández Robledo E; Alvarez AB; Marchena Bequer JJ; González Alemán M; Villain Plous C
Rev Cubana Med Trop; 2007; 59(1):52-8. PubMed ID: 23427419
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and resistance patterns of extended-spectrum and AmpC β-lactamase in Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis, and Salmonella serovar Stanley in a Korean tertiary hospital.
Park SD; Uh Y; Lee G; Lim K; Kim JB; Jeong SH
APMIS; 2010 Oct; 118(10):801-8. PubMed ID: 20854475
[TBL] [Abstract][Full Text] [Related]
13. Inhibitor-based methods for detection of plasmid-mediated AmpC beta-lactamases in Klebsiella spp., Escherichia coli, and Proteus mirabilis.
Coudron PE
J Clin Microbiol; 2005 Aug; 43(8):4163-7. PubMed ID: 16081966
[TBL] [Abstract][Full Text] [Related]
14. Extended-spectrum β-lactamase (ESBL) in Danish clinical isolates of Escherichia coli and Klebsiella pneumoniae: prevalence, β-lactamase distribution, phylogroups, and co-resistance.
Hansen DS; Schumacher H; Hansen F; Stegger M; Hertz FB; Schønning K; Justesen US; Frimodt-Møller N;
Scand J Infect Dis; 2012 Mar; 44(3):174-81. PubMed ID: 22364227
[TBL] [Abstract][Full Text] [Related]
15. CTX-M-15-producing Escherichia coli clone B2-O25b-ST131 and Klebsiella spp. isolates in municipal wastewater treatment plant effluents.
Dolejska M; Frolkova P; Florek M; Jamborova I; Purgertova M; Kutilova I; Cizek A; Guenther S; Literak I
J Antimicrob Chemother; 2011 Dec; 66(12):2784-90. PubMed ID: 21954457
[TBL] [Abstract][Full Text] [Related]
16. Molecular characterization of extended-spectrum beta-lactamase producing Enterobacteriaceae in a Saudi Arabian tertiary hospital.
Hassan H; Abdalhamid B
J Infect Dev Ctries; 2014 Mar; 8(3):282-8. PubMed ID: 24619257
[TBL] [Abstract][Full Text] [Related]
17. Comparison of 3 phenotypic-detection methods for identifying plasmid-mediated AmpC beta-lactamase-producing Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis strains.
Lee W; Jung B; Hong SG; Song W; Jeong SH; Lee K; Kwak HS
Korean J Lab Med; 2009 Oct; 29(5):448-54. PubMed ID: 19893354
[TBL] [Abstract][Full Text] [Related]
18. [Prevalence of extended-spectrum beta-lactamases in nosocomial Escherichia coli and Klebsiella spp. strains isolated from blood cultures].
Zarakolu P; Metan G; Hasçelik G; Akova M
Mikrobiyol Bul; 2007 Oct; 41(4):579-84. PubMed ID: 18173077
[TBL] [Abstract][Full Text] [Related]
19. Laboratory identification, risk factors, and clinical outcomes of patients with bacteremia due to Escherichia coli and Klebsiella pneumoniae producing extended-spectrum and AmpC type β-lactamases.
Tsui K; Wong SS; Lin LC; Tsai CR; Chen LC; Huang CH
J Microbiol Immunol Infect; 2012 Jun; 45(3):193-9. PubMed ID: 22580086
[TBL] [Abstract][Full Text] [Related]
20. Detection of extended-spectrum beta-lactamases among Enterobacteriaceae by use of semiautomated microbiology systems and manual detection procedures.
Wiegand I; Geiss HK; Mack D; Stürenburg E; Seifert H
J Clin Microbiol; 2007 Apr; 45(4):1167-74. PubMed ID: 17287329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]